Obiettivo LipidDrive is a breakthrough cloud computing platform and mobile app that allows researchers in the growing field of lipidomics to process, store and share analytical data in a standardized format.Lipidomics is the study of lipid molecules in cells, tissues and biofluids. Due to its low cost, high accuracy and deep insights into cellular function, it has the potential to revolutionize medical science. However it is blocked by a lack of data standardization, processing capacity and collaboration.There are no common protocols for lipidomics data output. 70% of lipidomics data is incomparible, wasting €14 million in research costs annually. Tests require large computer processing power, which most researchers do not possess. There are few online resources for data collaboration.Addressing these challenges, LipidDrive is a cloud-based platform for high-quality lipidomics data analysis. Users upload mass spectrometry data sets, which are processed by algorithms to ensure quality control, and are output according to new data standards. LipidDrive’s cloud computing service processes high-throughput data in any format, replacing desktop-based software with limited capacity. It also provides an online resource of latest research, lipid and biomarker libraries, communication tools and APIs for third-party data utilization.LipidDrive is an unrivaled ICT service developed by Dr Kim Ekroos, a leading lipidomics expert. It will target researchers in universities, pharmaceutical and nutritional industries, and hospitals and clinics through direct sales and partnerships with hardware vendors. Demand and willingness to pay have been confirmed by interest from several large pharmaceutical companies.Lipidomics is expected to follow the growth path of proteomics, which is worth €20 billion annually. LipidDrive will become the most valuable online resource for this fast-emerging industry. The proposed feasibility study will test the technology and prepare for commercialization. Campo scientifico natural sciencescomputer and information sciencesdata sciencenatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomicssocial scienceseconomics and businessbusiness and managementcommercee-commercenatural sciencesbiological sciencesbiochemistrybiomoleculeslipidsnatural scienceschemical sciencesanalytical chemistrymass spectrometry Programma(i) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.4. - Active ageing and self-management of health H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument H2020-EU.3.1.6. - Health care provision and integrated care Argomento(i) SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well Invito a presentare proposte H2020-SMEInst-2016-2017 Vedi altri progetti per questo bando Bando secondario H2020-SMEINST-1-2016-2017 Meccanismo di finanziamento SME-1 - SME instrument phase 1 Coordinatore LIPIDOMICS CONSULTING OY AB - LIPIDOMICS CONSULTING LTD Contribution nette de l'UE € 50 000,00 Indirizzo IRISVIKSVÄGEN 31 D 02230 Esbo Finlandia Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Regione Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 71 429,00
